U.S. officials have recovered a panel that blew off an Alaska Airlines airliner triggering a partial grounding of Boeing’s 737 MAX 9 and sending shares in the planemaker tumbling on Monday.
Oil prices fell by more than 2% on Monday on sharp price cuts by top exporter Saudi Arabia and a rise in OPEC output, offsetting supply concerns generated by escalating geopolitical tension in the Middle East.
Johnson & Johnson said on Monday it had agreed to buy drug developer Ambrx Biopharma for $2 billion to gain access to its portfolio of targeted cancer therapies.
Merck & Co said on Monday it would buy cancer drug developer Harpoon Therapeutics for about $680 million, reinforcing its oncology portfolio with immunotherapies.
German logistics company DHL Group is advising customers to take a close look at how they manage inventories as shippers switch away from the Red Sea, though trade associations said they did not expect any notable disruptions for Europe’s top economy.
Regeneron Pharmaceuticals on Monday reported eye drug Eylea’s fourth-quarter U.S. preliminary sales, which came below Wall Street expectations, as the company’s blockbuster product faced pressure from a rival.
Abercrombie & Fitch on Monday raised its forecast for fourth-quarter and annual net sales, after strong demand for its apparel brands during the key holiday shopping period.
Moderna on Monday reported preliminary 2023 sales of $6.7 billion for its COVID vaccine, surpassing the lower end of its full-year forecast, while reiterating its goal of returning to sales growth in 2025.
The cockpit voice recorder data on the Alaska Airlines Boeing 737 MAX 9 jet which lost a panel mid-flight on Friday was overwritten, U.S. authorities said, renewing attention on an industry call for longer in-flight recordings.
